IGFBP3 and colorectal carcinoma: Taken together with the current study demonstrating decreased functional IGFBP-3 in circulation due to NSP-induced IGFBP-3 proteolysis in a CAC mouse model, these findings suggest that systemic IGFBP-3 appears to be critical for the pathogenesis/pathophysiology of both colonic inflammation and CRC.